Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

6.94

-0.10 (-1.42%)

At close: Mar 24, 2026, 4:00 PM EDT

6.99

+0.05 (0.72%)

After-hours: Mar 24, 2026, 6:17 PM EDT

Gyre Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	52.43	26.67	33.51	25.18	44.35
Short-Term Investments	-	-	-	-	2.5
Cash & Short-Term Investments	52.43	26.67	33.51	25.18	46.85
Cash Growth	96.56%	-20.41%	33.10%	-46.27%	-40.96%
Accounts Receivable	31.08	19.59	15.16	17.14	1.82
Other Receivables	5.87	9.56	1.68	-	-
Total Trade Receivables	36.95	29.15	16.84	17.14	1.82
Inventory	-	-	4.28	6.12	-
Other Current Assets	2.83	2.63	2.59	1.22	2.81
Total Current Assets	102.37	64.79	57.22	49.65	51.48
Net Property, Plant & Equipment	24.73	25.7	23.76	18.38	3.71
Other Intangible Assets	4.73	0.27	0.21	0.3	-
Other Long-Term Assets	34.31	34.65	11.91	16.43	0.47
Total Assets	166.13	125.41	116.54	84.75	55.66
Accounts Payable	0.12	0.11	0.36	0.12	6.42
Accrued Expenses	14.35	10.62	11.94	9.26	5.54
Current Portion of Leases	0.64	0.71	0.21	0.49	1.98
Unearned Revenue	0.01	0.06	0.04	0.15	0.23
Other Current Liabilities	3.17	8.02	7.51	2.22	-
Total Current Liabilities	18.29	19.52	20.05	12.24	14.17
Long-Term Leases	0.3	0.89	0.2	0.12	0.41
Other Long-Term Liabilities	5.26	6.6	17.82	0.17	-
Total Long-Term Liabilities	5.56	7.49	18.02	0.29	0.41
Total Liabilities	23.85	27	38.07	12.54	14.57
Common Stock	0.09	0.09	0.08	0.06	0.03
Additional Paid-in Capital	172.05	136.19	68.18	32.8	443.75
Accumulated Other Comprehensive Income	-0.78	-2.6	-1.64	-0.39	-
Retained Earnings	-65.33	-70.36	-82.44	10.06	-402.69
Total Common Shareholders' Equity	106.03	63.32	-15.83	42.52	41.09
Minority Interest	36.25	35.08	94.3	29.7	-
Shareholders' Equity	142.28	98.4	13.95	72.22	41.09
Total Liabilities & Equity	166.13	125.41	116.54	84.75	55.66
Total Debt	0.94	1.6	0.41	0.61	2.39
Net Cash (Debt)	51.49	25.07	33.1	24.56	44.47
Net Cash Growth	105.34%	-24.25%	34.76%	-44.76%	-42.78%
Net Cash Per Share	0.50	0.24	0.50	0.33	0.67
Book Value	106.03	63.32	-15.83	42.52	41.09
Book Value Per Share	1.03	0.62	-0.24	0.56	0.62
Tangible Book Value	101.3	63.05	-16.03	42.23	41.09
Tangible Book Value Per Share	0.98	0.62	-0.24	0.56	0.62

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q